Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | EED | O75530 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL247066 | 1.00 | CYP3A4 (0.71) | CYP3A4PSIP1MAPK14NR1I2EED | |
| SCHEMBL244246 | 1.00 | CYP3A4 (0.71) | CYP3A4PSIP1MAPK14NR1I2EED | |
| SCHEMBL241605 | 0.94 | CYP3A4 (0.69) | CYP3A4PSIP1MAPK14NR1I2 | |
| SCHEMBL3320041 | 0.94 | CYP3A4 (0.71) | CYP3A4PSIP1MAPK14NR1I2 | |
| SCHEMBL3300020 | 0.93 | CYP3A4 (0.61) | CYP3A4PSIP1 | |
| SCHEMBL244094 | 0.93 | CYP3A4 (0.69) | CYP3A4PSIP1MAPK14NR1I2 | |
| SCHEMBL20021188 | 0.93 | CYP3A4 (0.69) | CYP3A4PSIP1MAPK14NR1I2 | |
| SCHEMBL15186198 | 0.93 | CYP3A4 (0.69) | CYP3A4PSIP1MAPK14NR1I2 | |
| SCHEMBL15182844 | 0.93 | CYP3A4 (0.60) | CYP3A4 | |
| SCHEMBL245426 | 0.92 | CYP3A4 (0.68) | CYP3A4PSIP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2588455-B1 | 2-QUINOLINYL-ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2018-04-04 | — | — | EP | disclosed |
| US-9296758-B2 | 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds | GILEAD SCIENCES, INC. (US) | 2016-03-29 | — | — | US | disclosed |
| EP-2588455-A1 | 2 -QUINOLINYL- ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS | Gilead Sciences, Inc. (US) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012003498-A1 | 2 -QUINOLINYL- ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2012-01-05 | — | — | WO | disclosed |